SDGR Projected Dividend Yield

Schrodinger Inc ( NASDAQ : SDGR )

Schrodinger is engaged in developing a physics-based software platform that enables discovery of molecules for drug development and materials applications. Co.'s software platform is used by biopharmaceutical and industrial companies, academic institutions, and government laboratories around the world. Co. has two segments: software, which is focused on selling its software to transform drug discovery across the life sciences industry, as well as to customers in materials science industries; and drug discovery, which is focused on various portfolio of preclinical and clinical programs, internally and through collaborations, that have developed to various stages of discovery and development.

20 YEAR PERFORMANCE RESULTS